Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
ADRX

ADARx Pharmaceuticals (ADRX) stock: insider trades, news & valuation

Health Care · Strong buying
Close · Oct 9, 2026 $17.78 +0.6% on the day -8.1% over 12 months 52-week range $17.33 – $20.64

Share price and insider trades

ADRX closeInsider buyInsider sale
1718192021OctBought $87,745,772 on 2026-09-28 · Carl L Gordon, Erez Chimovits, Orbimed Genesis Gp Llc, Simeon George, Sr One Capital Management, Llc
Bought, 12 months$87.7M
Sold, 12 months$0
Insiders buying5
Insiders selling0

ADARx Pharmaceuticals insider trading at a glance (Oct 9, 2026): in the past 12 months, 5 insiders bought $87.7M and 0 sold $0 of ADRX stock on the open market, including a cluster buy that began Sep 28, 2026.

ADRX insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q3 2026: $87.7M bought (13 trades)$87.7MQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$87.7M13—0

Valuation, profit and volume

Pick score 69/100
P/E (trailing)n/aSector median 24.7
Market value$1.90BBiotechnology
Profit margin0.0%Revenue growth +258.7%
Volume vs. 50-day—Last 5 sessions
Insiders' paper profit+$4.0MOn all tracked purchases +4.6%

Summary

Over the past 12 months, 5 ADARx Pharmaceuticals, Inc. insiders reported open-market purchases totaling $87.7M, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Sep 28, 2026, when 5 insiders bought a combined $87.7M. Among insiders with enough purchase history to measure, Simeon George (Director) has the highest Insider Score at 64.

ADRX stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Sep 30SEC Carl L GordonDirector Buy 588,235new position $17.00 $10.0M +4.6% —
Sep 30SEC Orbimed Genesis Gp LlcDirector Buy 588,235new position $17.00 $10.0M +4.6% —
Sep 30SEC Carl L GordonDirector Buy 300,24914,325,529 held (+2%) $17.00 $5.1M +4.6% —
Sep 30SEC Orbimed Genesis Gp LlcDirector Buy 300,24914,325,529 held (+2%) $17.00 $5.1M +4.6% —
Sep 30SEC Carl L GordonDirector Buy 61,5169,292,025 held (+1%) $17.00 $1.0M +4.6% —
Sep 30SEC Erez ChimovitsDirector Buy 61,5169,292,025 held (+1%) $17.00 $1.0M +4.6% —
Sep 30SEC Orbimed Genesis Gp LlcDirector Buy 61,5169,292,025 held (+1%) $17.00 $1.0M +4.6% —
Sep 29SEC Simeon GeorgeDirector Buy 592,5935,554,094 held (+12%) $17.00 $10.1M +4.6% 64
Sep 29SEC Simeon GeorgeDirector Buy 592,593new position $17.00 $10.1M +4.6% 64
Sep 29SEC Sr One Capital Management, Llc10% Owner Buy 592,5935,554,094 held (+12%) $17.00 $10.1M +4.6% —
Sep 29SEC Sr One Capital Management, Llc10% Owner Buy 592,593new position $17.00 $10.1M +4.6% —
Sep 29SEC Simeon GeorgeDirector Buy 414,8141,953,505 held (+27%) $17.00 $7.1M +4.6% 64
Sep 29SEC Sr One Capital Management, Llc10% Owner Buy 414,8141,953,505 held (+27%) $17.00 $7.1M +4.6% —

Insiders at ADARx Pharmaceuticals, Inc.

InsiderBoughtSoldLast filingScore
Simeon GeorgeDirector $27.2M — Sep 29, 2026 64
Sr One Capital Management, Llc10% Owner $27.2M — Sep 29, 2026 —
Carl L GordonDirector $16.1M — Sep 30, 2026 —
Orbimed Genesis Gp LlcDirector $16.1M — Sep 30, 2026 —
Erez ChimovitsDirector $1.0M — Sep 30, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought
  • ETRAElectra Therapeutics, Inc.$40.0M bought

ADRX stock: common questions

Are ADARx Pharmaceuticals, Inc. insiders buying ADRX stock?

In the past 12 months, 5 insiders reported open-market purchases of ADRX worth $87.7M. The latest was Director Carl L Gordon bought $10.0M of ADRX at $17.00 — first open-market purchase in our records; opens a new position.

Are ADARx Pharmaceuticals, Inc. insiders selling ADRX stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is ADRX's 52-week range?

Over the past year ADRX has traded between $17.33 and $20.64. It last closed at $17.78 on Oct 9, 2026.